0
Skip to Content
ICCFOP
Our Story
ICC Members
ICC Committees
Ask a Question
Contact
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Clinical Trial Committee Chair
FOP Doctors and Specialists
Link to Clinical Trials
FOP Publications
FOP Presentations
Press Releases
Member Area
Emergency Info
ICCFOP
Our Story
ICC Members
ICC Committees
Ask a Question
Contact
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Clinical Trial Committee Chair
FOP Doctors and Specialists
Link to Clinical Trials
FOP Publications
FOP Presentations
Press Releases
Member Area
Emergency Info
Folder: About Us
Back
Our Story
ICC Members
ICC Committees
Ask a Question
Contact
Folder: Treatment Guidelines
Back
Guidelines Home
Introduction
1. Abstract
2. Executive Summary
3. Background
4. Treatment
5. Special Medical Considerations
6. Treatment Considerations
7. Classes of Medications
8. Emergency Guidelines
9. Conclusions
10. Acknowledgments
11. Disclosures
12. Authors’ Contact Information
Brief Outlines
Guidelines QR Codes
Folder: Patients
Back
FOP Doctors and Specialists
Link to IFOPA Website
Link to Clinical Trials
Prepare for Clinical Trials
Folder: Industry
Back
Clinical Trial Committee Chair
Folder: Healthcare Providers
Back
FOP Doctors and Specialists
Link to Clinical Trials
Folder: Media
Back
FOP Publications
FOP Presentations
Press Releases
Member Area
Emergency Info

5. SPECIAL MEDICAL CONSIDERATIONS IN FOP

Dec 28
Written by Civiane Chung
Civiane Chung
Previous
Previous

4. THE PATHOLOGIC AND PATHOPHYSIOLOGIC-BASED TREATMENT OF FOP 
Next
Next

6. CURRENT TREATMENT CONSIDERATIONS 

Join our mailing list

Sign up to receive updates from us.

© 2026 The International Clinical Council (ICC) on Fibrodysplasia Ossificans Progressiva (FOP).

No results found